We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stago's Headquarters Move to New Building

By LabMedica International staff writers
Posted on 22 Apr 2014
Hemostasis specialist Stago (Asnières sur Seine, France) has moved its headquarters to a new building fully dedicated to its business activities. The functional, and contemporary 8,300 m² building is designed to accommodate not only the Group’s various global functions but also the activities of its French subsidiary. It will allow the company to optimize its everyday operations and to greet partners and customers in an even more welcoming environment.

Officially recognised as a low-energy, high environmental quality building, this development is part of a sustainable quality approach embodying the values that have guided Stago for nearly 70 years. This investment is an indicator of the company’s healthy balance sheet. It was made possible by its employees’ expertise and hard work, and above all by the strong support of the hemostasis scientific and medical community.

Image: Stago\'s New Building (Photo courtesy of Stago).
Image: Stago\'s New Building (Photo courtesy of Stago).

Patrick Monnot, deputy vice president Stago, commented, “The rapid acceleration in our international expansion meant we needed a new Head Office, more closely reflecting the Stago image and its operations today.”

Related Links:

Stago



Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Rocking Shaker
HumaRock
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests